Indoleamine-2,3-dioxygenase

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Revision as of 16:55, May 1, 2020 by Notjusttired (talk | contribs) (into plus links)

Indoleamine-2,3-dioxygenase or IDO is an enzyme involved in the human body's metabolism of the essential amino acid tryptophan.[1]

The IDO enzyme degrades (converts) tryptophan into kynurenine, and this process is strongly linked to the IDO1 and IDO2 genes.[1][2]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. ↑ 1.0 1.1 Bilir, Cemil; Sarisozen, Can (July 1, 2017). "Indoleamine 2,3-dioxygenase (IDO): Only an enzyme or a checkpoint controller?". Journal of Oncological Sciences. 3 (2): 52–56. doi:10.1016/j.jons.2017.04.001. ISSN 2452-3364.
  2. ↑ National Center for Biotechnology Information (March 22, 2020). "IDO1 indoleamine 2,3-dioxygenase 1 [Homo sapiens (human)] - Gene - NCBI". www.ncbi.nlm.nih.gov. Retrieved May 1, 2020. Cite has empty unknown parameter: |dead-url= (help)

indoleamine (IDO) - any derivatives of an indole (e.g., serotonin, tryptophan) that contain an amine group

indoleamine (IDO) - any derivatives of an indole (e.g., serotonin, tryptophan) that contain an amine group

indole (IDO) - a signalling molecule produced by bacteria as a result of metabolising tryptophan, found in the intestines

enzyme a substance produced by a living organism which acts as a catalyst to bring about a specific biochemical reaction.

Retrieved from "https://me-pedia.org/w/index.php?title=Indoleamine-2,3-dioxygenase&oldid=81466"